Okebo
NDC Package 69482-475-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Okebo is a medication used to treat a wide variety of bacterial infections, including those that cause acne. Marketed by Encore Dermatology Inc., this product is identified by NDC 69482-475 and is authorized under FDA application ANDA204234.

Identification & Billing

NDC Package Code
69482-475-06
Package Description
6 CAPSULE in 1 BOTTLE
Product Code
69482-475
11-Digit Billing Format
69482047506
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Okebo
Dosage Form
-
Usage Information
This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Regulatory & Marketing

Labeler Name
Encore Dermatology Inc.
FDA Application #
ANDA204234
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
11-20-2017
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69482-475). Click a package code to view its specific billing and regulatory data.

69482-475-99
100 CAPSULE in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69482-475-06 identifies a specific commercial package of 6 capsule in 1 bottle of Okebo, labeled by Encore Dermatology Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Encore Dermatology Inc. on November 20, 2017. The current certification is valid through December 31, 2021.

What are the primary indications for this medication?

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

How is this Encore Dermatology Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69482047506. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69482-475-06
11-Digit CMS (5-4-2)
69482-0475-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.